Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea-Reference-Cited by-同舟云学术

Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea

Published:2003-01 Issue:6 Volume:21 Page:287-292
ISSN:0213-005X
Container-title:Enfermedades Infecciosas y Microbiología Clínica
language:es
Short-container-title:Enfermedades Infecciosas y Microbiología Clínica

Author:

Rivero Antonio,López-Cortés Luis,Castillo Rafael,Lozano Fernando,Ángel García Miguel,Díez Felip,Carlos Escribano José,Canueto Jesús,Pasquau Juan,José Hernández Juan,Polo Rosa,Javier Martínez-Marcos Francisco,María Kindelán José,Rey Rafael

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference29 articles.

1. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy;Selwyn;JAMA,1992

2. Risk for developing tuberculosis among anergic patients infected with HIV;Moreno;Ann Intern Med,1993

3. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis;Gordin;N Engl J Med,1997

4. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus;Whalen;N Engl J Med,1997

5. >Centers for Disease Control. PPD-tuberculin anergy in persons with HIV infection. Guidelines for anergy testing and management of anergic persons at risk of tuberculous infection;MMWR,1991

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Different Drug Regimens for Tuberculosis Preventive Treatment: A Systematic Review and Meta-Analysis;Cureus;2023-04-26

2. Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB;Current HIV/AIDS Reports;2020-09-12

3. Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020;American Journal of Transplantation;2020-03-28

4. Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials;The Lancet Infectious Diseases;2020-03

5. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020;MMWR. Recommendations and Reports;2020-02-14